These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 37833898)

  • 1. Mitochondria and Oxidative Stress as a Link between Alzheimer's Disease and Diabetes Mellitus.
    Veselov IM; Vinogradova DV; Maltsev AV; Shevtsov PN; Spirkova EA; Bachurin SO; Shevtsova EF
    Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37833898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetes and Alzheimer disease, two overlapping pathologies with the same background: oxidative stress.
    Rosales-Corral S; Tan DX; Manchester L; Reiter RJ
    Oxid Med Cell Longev; 2015; 2015():985845. PubMed ID: 25815110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin signalling in Alzheimer's disease and diabetes: from epidemiology to molecular links.
    Ribe EM; Lovestone S
    J Intern Med; 2016 Nov; 280(5):430-442. PubMed ID: 27739227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mechanisms of neurodegeneration in Alzheimer's disease].
    Jovanović Z
    Med Pregl; 2012; 65(7-8):301-7. PubMed ID: 22924250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic defects shared by Alzheimer's disease and diabetes: A focus on mitochondria.
    Carvalho C; Moreira PI
    Curr Opin Neurobiol; 2023 Apr; 79():102694. PubMed ID: 36842275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potential role of Keap1-Nrf2 pathway in the pathogenesis of Alzheimer's disease, type 2 diabetes, and type 2 diabetes-related Alzheimer's disease.
    He L; Sun Y
    Metab Brain Dis; 2021 Oct; 36(7):1469-1479. PubMed ID: 34129198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin signaling, glucose metabolism and mitochondria: major players in Alzheimer's disease and diabetes interrelation.
    Correia SC; Santos RX; Carvalho C; Cardoso S; Candeias E; Santos MS; Oliveira CR; Moreira PI
    Brain Res; 2012 Mar; 1441():64-78. PubMed ID: 22290178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Common neurodegenerative pathways in obesity, diabetes, and Alzheimer's disease.
    Pugazhenthi S; Qin L; Reddy PH
    Biochim Biophys Acta Mol Basis Dis; 2017 May; 1863(5):1037-1045. PubMed ID: 27156888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic Metabolism and Mitochondria in the Mechanism of Alzheimer's Disease: Finding Potential Therapeutic Targets.
    Song M; Fan X
    Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial Disorders in Alzheimer's Disease.
    Sukhorukov VS; Mudzhiri NM; Voronkova AS; Baranich TI; Glinkina VV; Illarioshkin SN
    Biochemistry (Mosc); 2021 Jun; 86(6):667-679. PubMed ID: 34225590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of oxidative stress and other pathologies in Alzheimer's disease.
    Simunkova M; Alwasel SH; Alhazza IM; Jomova K; Kollar V; Rusko M; Valko M
    Arch Toxicol; 2019 Sep; 93(9):2491-2513. PubMed ID: 31440798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain mitochondrial dysfunction as a link between Alzheimer's disease and diabetes.
    Moreira PI; Santos MS; Seiça R; Oliveira CR
    J Neurol Sci; 2007 Jun; 257(1-2):206-14. PubMed ID: 17316694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Common Pathological Mechanisms and Risk Factors for Alzheimer's Disease and Type-2 Diabetes: Focus on Inflammation.
    Moyse E; Haddad M; Benlabiod C; Ramassamy C; Krantic S
    Curr Alzheimer Res; 2019; 16(11):986-1006. PubMed ID: 31692443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type 2 Diabetes Mellitus and Alzheimer's Disease: Shared Molecular Mechanisms and Potential Common Therapeutic Targets.
    Hamzé R; Delangre E; Tolu S; Moreau M; Janel N; Bailbé D; Movassat J
    Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Verapamil attenuates scopolamine induced cognitive deficits by averting oxidative stress and mitochondrial injury - A potential therapeutic agent for Alzheimer's Disease.
    Ponne S; Kumar CR; Boopathy R
    Metab Brain Dis; 2020 Mar; 35(3):503-515. PubMed ID: 31691145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Connecting Alzheimer's disease to diabetes: Underlying mechanisms and potential therapeutic targets.
    Vieira MNN; Lima-Filho RAS; De Felice FG
    Neuropharmacology; 2018 Jul; 136(Pt B):160-171. PubMed ID: 29129775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Focus on the Correlations between Alzheimer's Disease and Type 2 Diabetes.
    Fiore V; De Rosa A; Falasca P; Marci M; Guastamacchia E; Licchelli B; Giagulli VA; De Pergola G; Poggi A; Triggiani V
    Endocr Metab Immune Disord Drug Targets; 2019; 19(5):571-579. PubMed ID: 30854980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial dysfunction and beneficial effects of mitochondria-targeted small peptide SS-31 in Diabetes Mellitus and Alzheimer's disease.
    Ding XW; Robinson M; Li R; Aldhowayan H; Geetha T; Babu JR
    Pharmacol Res; 2021 Sep; 171():105783. PubMed ID: 34302976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alzheimer's disease and diabetes: an integrative view of the role of mitochondria, oxidative stress, and insulin.
    Moreira PI
    J Alzheimers Dis; 2012; 30 Suppl 2():S199-215. PubMed ID: 22269163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic Syndrome, Brain Insulin Resistance, and Alzheimer's Disease: Thioredoxin Interacting Protein (TXNIP) and Inflammasome as Core Amplifiers.
    Nasoohi S; Parveen K; Ishrat T
    J Alzheimers Dis; 2018; 66(3):857-885. PubMed ID: 30372683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.